of ELAC2 in prostate cancer, suggest moderate familial risk, and estimate that risk genotypes in ELAC2 may cause 2% of prostate cancer in the general population.
暂无分享,去创建一个
N. Camp | J. Schleutker | A. Rökman | N. Mononen | A. Wein | C. Zeigler-Johnson | Autio | S. Weisburg | Kirkwood Br | Sean V. T Avtigian